Transcatheter repair for leaky tricuspid valve during heart surgery
Part of Heart & circulation clinical trials.
This trial studies a catheter-based repair to help fix a leaky tricuspid valve (regurgitation), especially when you’re also having another heart surgery. It aims to improve valve function and symptoms while tracking safety and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have long-term “functional” tricuspid valve leakage that is at least moderate
- You’re 18 to 85 years old
- Your heart pumping strength is adequate (left ventricle ejection fraction 30% or higher)
- You have to be in NYHA heart-failure symptom class II, III, or able to walk around but with more severe symptoms (ambulatory IV)
- You’re scheduled for a heart operation using a heart-lung machine (surgical arm only)
- You can sign consent and complete the study visits and tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This trial is testing a new, less-invasive device to fix the tricuspid valve in the heart for people with severe leakage. It may be an option if you are not a good candidate for traditional open-heart surgery and have tried other treatments.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This study looks at whether fixing a mildly leaky tricuspid valve during LVAD surgery improves outcomes for people with advanced heart failure. It’s mainly aimed at patients who are already scheduled to receive an implantable LVAD.
This study looks at whether doing a tricuspid valve repair at the same time as left-heart valve surgery is helpful for people who have mild tricuspid valve leakage. It may reduce future valve problems, but your eligibility depends on your heart valve type and recent health history.
This study tests a new, catheter-based procedure to treat moderate-to-severe leaking of the tricuspid valve (a heart valve on the right side). It’s for people who are high surgical risk and might benefit from replacing the valve without open-heart surgery.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.